OZ Biosciences Overview
- Founded
-
2003

- Status
-
Private
- Employees
-
16

- Latest Deal Type
-
Seed
- Investors
-
3
OZ Biosciences General Information
Description
Developer of molecular delivery systems designed for transfection and transduction. The company product line includes magnetoreception which uses magnetic drug targeting technology, lipofection lipid-based transfection technology, genome editing transfection reagents, transduction tools, 3D transfection reagents, protein delivery systems, and vaccine adjuvants, enabling customers transfection and transduction.
Contact Information
Website
www.ozbiosciences.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
- Parc scientifique de Luminy Zone Luminy Entreprise
- 163 Avenue de Luminy, cedex 9
- 13288 Marseille
- France
+33 04 00 00 00 00
OZ Biosciences Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
2. Seed Round | 01-Sep-2009 | Completed | Generating Revenue | |||
1. Accelerator/Incubator | Completed | Startup |
OZ Biosciences Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of molecular delivery systems designed for transfection and transduction. The company product line includes ma
Biotechnology
Marseille, France
16
As of 2023
000000000
OZ Biosciences Competitors (8)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Mirus Bio | Private Equity-Backed | Madison, WI | 00 | 000000000000 | ||
000000000 | Corporation | San Diego, CA | 00 | 0000000000 | ||
00000000-000000000 | Private Equity-Backed | Illkirch-Graffenstaden, France | 000 | 000.00 | 000000&0 | |
0000000 | Formerly PE-Backed | Madison, WI | 0000 | 000000000000 | ||
000000 | Formerly VC-backed | Hilden, Germany | 0000 | 00000 | 000000&0 |
OZ Biosciences Patents
OZ Biosciences Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
AU-2020314617-A1 | Cationic poloxamers and their use in transduction | Pending | 18-Jul-2019 | 000000000 | |
CA-3140460-A1 | Cationic poloxamers and their use in transduction | Pending | 18-Jul-2019 | 000000000 | |
EP-3999649-A1 | Cationic poloxamers and their use in transduction | Pending | 18-Jul-2019 | 000000000 | |
EP-3766981-A1 | Cationic poloxamers and their use in transduction | Pending | 18-Jul-2019 | 000000000 | 0 |
US-20220267803-A1 | Cationic poloxamers and their use in transduction | Pending | 18-Jul-2019 | C12N15/87 |
OZ Biosciences Executive Team (1)
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Olivier Zelphati Ph.D | Chief Executive Officer, President & Chairman |
OZ Biosciences Board Members (1)
Name | Representing | Role | Since |
---|---|---|---|
Olivier Zelphati Ph.D | OZ Biosciences | Chief Executive Officer, President & Chairman | 000 0000 |
OZ Biosciences Signals
OZ Biosciences Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Impulse VC | Venture Capital | Minority | 000 0000 | 000000 0 | |
Grand Luminy | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | |
Incubateur Impulse | Accelerator/Incubator | Minority | 000 0000 | 000000 0 |